Sökning: WFRF:(Östlund A.)
> (2020-2024) >
FFR-Guided Complete...
-
Böhm, FelixThe Department of Cardiology, Karolinska Institute, Danderyd Hospital, Danderyd, Sweden,Karolinska Inst, Sweden; Danderyd Hosp, Sweden
(författare)
FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction
- Artikel/kapitelEngelska2024
Förlag, utgivningsår, omfång ...
-
Massachusetts Medical Society,2024
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:kth-346380
-
https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-346380URI
-
https://doi.org/10.1056/NEJMoa2314149DOI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-224128URI
-
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-202472URI
-
https://gup.ub.gu.se/publication/336923URI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:155470621URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
QC 20240521
-
Funding Agencies|Swedish Research Council [2015-00884]; Swedish Heart-Lung Foundation [20150521]; Stockholm County Council (ALF project) [RS2020-0731]; Abbott; Boston Scientific
-
BACKGROUND: The benefit of fractional flow reserve (FFR)-guided complete revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease remains unclear. METHODS: In this multinational, registry-based, randomized trial, we assigned patients with STEMI or very-high-risk non-STEMI (NSTEMI) and multivessel disease who were undergoing primary percutaneous coronary intervention (PCI) of the culprit lesion to receive either FFR-guided complete revascularization of nonculprit lesions or no further revascularization. The primary outcome was a composite of death from any cause, myocardial infarction, or unplanned revascularization. The two key secondary outcomes were a composite of death from any cause or myocardial infarction and unplanned revascularization. RESULTS: A total of 1542 patients underwent randomization, with 764 assigned to receive FFR-guided complete revascularization and 778 assigned to receive culprit-lesion-only PCI. At a median follow-up of 4.8 years (interquartile range, 4.3 to 5.2), a primary-outcome event had occurred in 145 patients (19.0%) in the complete-revascularization group and in 159 patients (20.4%) in the culprit-lesion-only group (hazard ratio, 0.93; 95% confidence interval [CI], 0.74 to 1.17; P = 0.53). With respect to the secondary outcomes, no apparent between-group differences were observed in the composite of death from any cause or myocardial infarction (hazard ratio, 1.12; 95% CI, 0.87 to 1.44) or unplanned revascularization (hazard ratio, 0.76; 95% CI, 0.56 to 1.04). There were no apparent between-group differences in safety outcomes. CONCLUSIONS: Among patients with STEMI or very-high-risk NSTEMI and multivessel coronary artery disease, FFR-guided complete revascularization was not shown to result in a lower risk of a composite of death from any cause, myocardial infarction, or unplanned revascularization than culprit-lesion-only PCI at 4.8 years. (Funded by the Swedish Research Council and others; FULL REVASC ClinicalTrials.gov number, NCT02862119.).
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Mogensen, BrynjölfurThe Department of Cardiology, Karolinska Institutet, Danderyd Hospital,Karolinska Inst, Sweden; Danderyd Hosp, Sweden
(författare)
-
Engstrøm, ThomasThe Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark,Univ Copenhagen, Denmark
(författare)
-
Stankovic, GoranThe University Clinical Center of Serbia, The Faculty of Medicine, University of Belgrade, Belgrade, Serbia,Univ Belgrade, Serbia
(författare)
-
Srdanovic, IlijaThe Faculty of Medicine, University of Novi Sad, Institute of Cardiovascular Diseases Vojvodina, Sremska Kamenica, Serbia,Univ Novi Sad, Serbia
(författare)
-
Lønborg, JacobThe Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark,Univ Copenhagen, Denmark
(författare)
-
Zwackman, SammyLinköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Region Östergötland, Kardiologiska kliniken US(Swepub:liu)samzw44
(författare)
-
Hamid, MehmetThe Department of Cardiology, Mälarsjukhuset, Eskilstuna, Sweden
(författare)
-
Kellerth, ThomasThe Department of Cardiology, Central Hospital, Karlstad, Sweden,Cent Hosp Karlstad, Sweden
(författare)
-
Lauermann, JörgThe Department of Cardiology, Ryhov Hospital, Jönköping, Sweden,Ryhov Hosp, Sweden
(författare)
-
Kajander, Olli A.The Heart Hospital, Tampere University Hospital, The Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland,Tampere Univ, Finland; Tampere Univ, Finland
(författare)
-
Andersson, JonasUmeå universitet,Kardiologi,Umea Univ Hosp, Sweden(Swepub:umu)joan0102
(författare)
-
Linder, RikardKarolinska Institutet
(författare)
-
Angerås, Oskar,1976Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine(Swepub:gu)xangos
(författare)
-
Renlund, HenrikThe Department of Medical Sciences, Uppsala University, Uppsala, Sweden,Uppsala Univ, Sweden
(författare)
-
Ērglis, AndrejsThe Latvian Center of Cardiology, Pauls Stradins Clinical University Hospital, University of Latvia, Riga, Latvia,Univ Latvia, Latvia
(författare)
-
Menon, MadhavThe Cardiology Department, Waikato Hospital, Hamilton, New Zealand,Waikato Hosp, New Zealand
(författare)
-
Schultz, CarlThe Medical School, University of Western Australia, The Department of Cardiology, Royal Perth Hospital, Perth, WA, Australia,Univ Western Australia, Australia; Royal Perth Hosp, Australia
(författare)
-
Laine, MikaThe Heart and Lung Center, Helsinki University Central Hospital, Helsinki, Finland,Helsinki Univ Cent Hosp, Finland
(författare)
-
Held, ClaesThe Department of Medical Sciences, Uppsala University, Uppsala, Sweden,Uppsala Univ, Sweden; Uppsala Univ, Sweden
(författare)
-
Rück, AndreasKarolinska Institutet
(författare)
-
Östlund, OllieThe Department of Medical Sciences, Uppsala University, Uppsala, Sweden,Uppsala Univ, Sweden
(författare)
-
James, StefanThe Department of Medical Sciences, Uppsala University, Uppsala, Sweden,Uppsala Univ, Sweden; Uppsala Univ, Sweden
(författare)
-
The Department of Cardiology, Karolinska Institute, Danderyd Hospital, Danderyd, SwedenKarolinska Inst, Sweden; Danderyd Hosp, Sweden
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:New England Journal of Medicine: Massachusetts Medical Society390:16, s. 1481-14920028-47931533-4406
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Böhm, Felix
-
Mogensen, Brynjö ...
-
Engstrøm, Thomas
-
Stankovic, Goran
-
Srdanovic, Ilija
-
Lønborg, Jacob
-
visa fler...
-
Zwackman, Sammy
-
Hamid, Mehmet
-
Kellerth, Thomas
-
Lauermann, Jörg
-
Kajander, Olli A ...
-
Andersson, Jonas
-
Linder, Rikard
-
Angerås, Oskar, ...
-
Renlund, Henrik
-
Ērglis, Andrejs
-
Menon, Madhav
-
Schultz, Carl
-
Laine, Mika
-
Held, Claes
-
Rück, Andreas
-
Östlund, Ollie
-
James, Stefan
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
New England Jour ...
- Av lärosätet
-
Kungliga Tekniska Högskolan
-
Umeå universitet
-
Linköpings universitet
-
Göteborgs universitet
-
Karolinska Institutet